Karnes W E, Berlin R G, Maxwell V, Sytnik B, Root J K, Walsh J H
CURE VA-Wadsworth, West Los Angeles, CA 90073.
Aliment Pharmacol Ther. 1990 Oct;4(5):443-56. doi: 10.1111/j.1365-2036.1990.tb00491.x.
Hypergastrinaemia induced by potent inhibitors of acid secretion is thought to occur as a result of the elimination of the inhibitory effects of intragastric acid on gastrin release. The present study was designed to determine if the mechanisms responsible for feedback inhibition of gastrin release and acid secretion by intragastric acid are preserved during four weeks of varying degrees of drug-induced acid inhibition. Forty-eight healthy male volunteers were randomly assigned to one of four treatments for four weeks: 10 mg omeprazole o.m., 20 mg omeprazole o.m., 40 mg omeprazole o.m. or 150 mg ranitidine b.d. Gastrin release and acid secretion in response to peptone meals maintained at pH 2.5 and pH 5.5 by intragastric titration, and 24-hour gastrin profiles in response to standard meals were determined before treatment, at the fourth week of treatment and two weeks after discontinuing treatment. As expected, omeprazole produced dose-related effects on acid secretion and gastrin concentrations that were largely reversed after treatment was discontinued. Gastrin release in response to pH 5.5 peptone meals remained significantly greater than gastrin release in response to pH 2.5 meals during treatment with all doses of omeprazole. The ratio of pH 5.5/pH 2.5 peptone meal-stimulated gastrin release was approximately 1.5, and remained constant for all treatment groups throughout the study period. These data indicate that four weeks of drug induced hypochlorhydria causes an apparent increase in overall G-cell function, but it does not interfere with normal feedback inhibition of gastrin release and acid secretion mediated by intragastric acidity.
强效胃酸分泌抑制剂诱发的高胃泌素血症被认为是由于胃内酸对胃泌素释放的抑制作用消除所致。本研究旨在确定在不同程度的药物诱导性酸抑制的四周期间,胃内酸对胃泌素释放和胃酸分泌的反馈抑制机制是否得以保留。48名健康男性志愿者被随机分配到四种治疗方案中的一种,为期四周:口服10毫克奥美拉唑、口服20毫克奥美拉唑、口服40毫克奥美拉唑或每日两次口服150毫克雷尼替丁。在治疗前、治疗第四周和停药两周后,测定了通过胃内滴定维持在pH 2.5和pH 5.5的蛋白胨餐刺激下的胃泌素释放和胃酸分泌,以及标准餐刺激下的24小时胃泌素谱。正如预期的那样,奥美拉唑对胃酸分泌和胃泌素浓度产生了剂量相关的影响,停药后这些影响在很大程度上得到了逆转。在所有剂量的奥美拉唑治疗期间,对pH 5.5蛋白胨餐的胃泌素释放仍显著大于对pH 2.5餐的胃泌素释放。pH 5.5/pH 2.5蛋白胨餐刺激的胃泌素释放比值约为1.5,并且在整个研究期间所有治疗组均保持恒定。这些数据表明,四周的药物诱导性胃酸过少会导致总体G细胞功能明显增加,但并不干扰由胃内酸度介导的胃泌素释放和胃酸分泌的正常反馈抑制。